Chronic Kidney Disease, Guidelines, and Newer Medications

Overview

Chronic kidney disease (CKD) affects millions and often goes undetected until it's advanced—making early recognition and intervention critical. In this session, you'll gain practical strategies for assessing CKD risk using both eGFR and urinary albumin, aligned with the latest KDIGO guidelines. Discover how lifestyle changes and weight management can complement medical therapy, and learn which newer medications effectively reduce proteinuria to slow disease progression. Faculty will share key insights to help you integrate updated CKD care approaches into everyday practice.

Learning Objectives

• Explore strategies to assess risk of kidney failure that incorporate both the eGFR and urinary albumin
• Consider additional approaches to CKD that emphasize lifestyle changes and weight loss
• Recognize the importance of medications that decrease proteinuria (albuminuria) to slow progression of chronic kidney disease